BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28516481)

  • 1. Massive mediastinal enlargement due to extramedullary haematopoiesis in a patient with MYH9-related thrombocytopenia.
    Zaninetti C; Boveri E; Melazzini F
    Br J Haematol; 2017 Jul; 178(1):10. PubMed ID: 28516481
    [No Abstract]   [Full Text] [Related]  

  • 2. May-Hegglin anomaly: morphologic and clinical manifestations.
    Saito H; Kunishima S
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):111-3. PubMed ID: 19367252
    [No Abstract]   [Full Text] [Related]  

  • 3. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.
    Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A
    Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of MYH9 disorders caused by a novel mutation (p.K74E).
    Kanematsu T; Suzuki N; Yoshida T; Kishimoto M; Aoki T; Ogawa M; Kagami Y; Kiyoi H; Matsushita T; Kunishima S
    Ann Hematol; 2016 Jan; 95(1):161-163. PubMed ID: 26382273
    [No Abstract]   [Full Text] [Related]  

  • 5. Early diagnosis improves the quality of life in MYH9 disorder.
    Shiota M; Kunishima S; Hamabata T; Nakata M; Hata D
    Pediatr Blood Cancer; 2012 Feb; 58(2):314-5. PubMed ID: 21796764
    [No Abstract]   [Full Text] [Related]  

  • 6. Extramedullary hematopoiesis: a new feature of inherited thrombocytopenias?
    Zaninetti C; Melazzini F; Croci GA; Boveri E; Balduini CL
    J Thromb Haemost; 2017 Nov; 15(11):2226-2229. PubMed ID: 28921865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia.
    Fabris F; Scandellari R; Vettore S; Scapin M; Bizzaro N; Randi ML
    Thromb Haemost; 2010 Oct; 104(4):858-9. PubMed ID: 20694274
    [No Abstract]   [Full Text] [Related]  

  • 8. Accumulation of MYH9 mRNA at leukocyte inclusion bodies in MYH9 disorders.
    Kunishima S; Hirano K; Hamaguchi M; Saito H
    Eur J Haematol; 2008 Oct; 81(4):325-6. PubMed ID: 18616507
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopenia.
    Yamanouchi J; Hato T; Kunishima S; Niiya T; Nakamura H; Yasukawa M
    Ann Hematol; 2015 Sep; 94(9):1599-600. PubMed ID: 26051904
    [No Abstract]   [Full Text] [Related]  

  • 10. A D1424N mutation in the MYH9 gene results in macrothrombocytopenia and granulocytic inclusion bodies in a Chinese inherited macrothrombocytopenia pedigree.
    Guo X; Lian X; Zhang W; Hao J
    Clin Chem Lab Med; 2018 Jun; 56(7):e171-e173. PubMed ID: 29451856
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombocytopenia and proteinuria. Nonmuscle myosin heavy-chain-9-related disease ( MYH9 RD) or Epstein syndrome (ES).
    Bhatt A; Broxson E; Witte D; Omoloja A
    Pediatr Nephrol; 2009 Mar; 24(3):485-8. PubMed ID: 18781340
    [No Abstract]   [Full Text] [Related]  

  • 12. The first two cases of MYH9 disorders in Thailand: an international collaborative study.
    Sirachainan N; Komwilaisak P; Kitamura K; Hongeng S; Sekine T; Kunishima S
    Ann Hematol; 2015 Apr; 94(4):707-9. PubMed ID: 25394719
    [No Abstract]   [Full Text] [Related]  

  • 13. MYH9 related platelet disorders - often unknown and misdiagnosed.
    Althaus K; Najm J; Greinacher A
    Klin Padiatr; 2011 May; 223(3):120-5. PubMed ID: 21567368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic and genetic characterization of an MYH9-related disorder in a Chinese family.
    Ma ES; Wong CL; Shek TW; Hui SP
    Haematologica; 2006 Jul; 91(7):1002-3. PubMed ID: 16818291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of a novel mutation leading to MYH9-related disease.
    Burt RA; Joseph JE; Milliken S; Collinge JE; Kile BT
    Thromb Res; 2008; 122(6):861-3. PubMed ID: 18676005
    [No Abstract]   [Full Text] [Related]  

  • 16. [Identification of MYH9 gene mutation in a May-Hegglin anomaly family].
    Gao F; Hao JH; Wang ZL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):660-2. PubMed ID: 23134864
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the understanding of MYH9 disorders.
    Kunishima S; Saito H
    Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.
    Murayama S; Akiyama M; Namba H; Wada Y; Ida H; Kunishima S
    Pediatr Int; 2013 Feb; 55(1):102-4. PubMed ID: 23409987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel MYH9 mutation in a patient with May-Hegglin anomaly.
    Otsubo K; Kanegane H; Nomura K; Ogawa J; Miyawaki T; Kunishima S
    Pediatr Blood Cancer; 2006 Dec; 47(7):968-9. PubMed ID: 16642488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.